Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis : the superior disease control of R-HDS does not translate into an overall survival advantageLADETTO, Marco; DE MARCO, Federica; GALLAMINI, Andrea et al.Blood. 2008, Vol 111, Num 8, pp 4004-4013, issn 0006-4971, 10 p.Article

Infliximab treatment for steroid-refractory acute graft-versus-host diseasePATRIARCA, Francesca; SPEROTTO, Alessandra; DINI, Giorgio et al.Haematologica (Roma). 2004, Vol 89, Num 11, pp 1352-1359, issn 0390-6078, 8 p.Article

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignanciesCORRADINI, Paolo; TARELLA, Corrado; CICERI, Fabio et al.Blood. 2002, Vol 99, Num 1, pp 75-82, issn 0006-4971Article

Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphomaLANZA, Francesco; LEMOLI, Roberto M; SCORTECHINI, Ilaria et al.Transfusion (Philadelphia, PA). 2014, Vol 54, Num 2, pp 331-339, issn 0041-1132, 9 p.Article

Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host diseaseSVEGLIATI, Silvia; OLIVIERI, Attilio; GABRIELLI, Armando et al.Blood. 2007, Vol 110, Num 1, pp 237-241, issn 0006-4971, 5 p.Article

Long-term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled-rate freezing and uncontrolled-rate freezing at 80°CMONTANARI, Mauro; CAPELLI, Debora; REFE, Cristina et al.Transfusion (Philadelphia, PA). 2003, Vol 43, Num 1, pp 42-49, issn 0041-1132, 8 p.Article

Imatinib for refractory chronic graft-versus-host disease with fibrotic featuresOLIVIERI, Attilio; LOCATELLI, Franco; GABRIELLI, Armando et al.Blood. 2009, Vol 114, Num 3, pp 709-718, issn 0006-4971, 10 p.Article

Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantationFARINA, Lucia; CARNITI, Cristiana; CORRADINI, Paolo et al.Haematologica (Roma). 2009, Vol 94, Num 5, pp 654-662, issn 0390-6078, 9 p.Article

Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma : a prospective, multicenter, phase II studyOFFIDANI, Massimo; CORVATTA, Laura; RUPOLI, Serena et al.Haematologica (Roma). 2006, Vol 91, Num 1, pp 133-136, issn 0390-6078, 4 p.Article

The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2MORELLI, Maria Beatrice; OFFIDANI, Massimo; ALESIANI, Francesco et al.International journal of cancer (Print). 2014, Vol 134, Num 11, pp 2534-2546, issn 0020-7136, 13 p.Article

Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot studyPOLONI, Antonella; CAPELLI, Debora; OLIVIERI, Attilio et al.British journal of haematology. 2010, Vol 150, Num 1, pp 119-121, issn 0007-1048, 3 p.Article

Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myelomaOFFIDANI, Massimo; CORVATTA, Laura; FERRANTI, Mario et al.Blood. 2006, Vol 108, Num 7, pp 2159-2164, issn 0006-4971, 6 p.Article

A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantationOFFIDANI, Massimo; CORVATTA, Laura; OLIVIERI, Attilio et al.Clinical infectious diseases. 2001, Vol 32, Num 10, pp 1414-1422, issn 1058-4838Article